Srivenn Formulations Private Limited
About Srivenn Formulations Private Limited
Data last updated:
Srivenn Formulations Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 2012.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51101TG2012PTC083273. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sapna Agarwal and Manoj Kumar Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 21 – 1 – 732/C/5 2nd Floor Gopal Market Rikab Gunj, Hyderabad, Telangana, India – 500002.
Company details
CIN history
Srivenn Formulations has one previous CIN (Corporate Identification Number): U51101AP2012PTC083273. The current CIN is U51101TG2012PTC083273, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51101TG2012PTC083273 | Current |
| U51101AP2012PTC083273 | Previous |
Contact details
Srivenn Formulations Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 – 1 – 732/C/5 2nd Floor Gopal Market Rikab Gunj, Hyderabad, Telangana, India – 500002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srivenn Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Srivenn Formulations Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srivenn Formulations Private Limited, buy the company report.
Board of directors of Srivenn Formulations Private Limited
Srivenn Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapna Agarwal Also directs: Affluence X Advisory Partners LLP, Hayden Trading Private Limited | Director | 25 Sep 2012 | 14 Years 1 Months | As last reported |
| Manoj Kumar Agarwal Also directs: Hayden Trading Private Limited | Director | 25 Sep 2012 | 14 Years 1 Months | As last reported |
Peer comparison
Srivenn Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RSND Formulations (OPC) Private Limited | ₹4.55 Lakh (FY 2025) | -34.0% | Mithoni, Uttar Pradesh, India | |||
| Biored Remedies Private Limited | ₹4.55 Lakh (FY 2025) | 98.0% | Krishnarajapuramhobli, Karnataka, India | |||
| VL Pharmaceuticals Private Limited | ₹4.52 Lakh (FY 2019) | 133.0% | Lucknow, Uttar Pradesh, India | |||
| Primd Pharma Private Limited | ₹4.51 Lakh (FY 2024) | 40.0% | Hyderabad, Telangana, India | |||
| Boots Healthcare Private Limited | ₹4.49 Lakh (FY 2024) | 8.0% | Delhi, India | |||
| Lumina Life Sciences India Limited | ₹4.42 Lakh (FY 2018) | -33.0% | Hyderabad, Telangana, India | |||
| Kcureit Pharmaceutical Private Limited | ₹4.42 Lakh (FY 2022) | Panipat, Haryana, India | ||||
| Ampus Life Sciences Limited | ₹4.38 Lakh (FY 2025) | 69.0% | Navi Mumbai, Maharashtra, India | |||
| Santa Pharma Private Limited | ₹4.36 Lakh (FY 2024) | -22.0% | Chandigarh, India | |||
| Maximore Pharma Private Limited | ₹4.31 Lakh (FY 2024) | -55.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Srivenn Formulations Private Limited, buy the company report.
Auditor
Srivenn Formulations Private Limited is audited by LUHARUKA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LUHARUKA & ASSOCIATES | FY 2022 | 001882S |
Shareholding
The shareholding of Srivenn Formulations Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Srivenn Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Srivenn Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srivenn Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Srivenn Formulations has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Srivenn Formulations Private Limited, buy the company report.
Recent activity
Srivenn Formulations Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Manoj Kumar Agarwal was appointed as Director on 25 Sep 2012.
Frequently asked questions
Srivenn Formulations has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Srivenn Formulations was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 25 September 2012 and is registered under CIN U51101TG2012PTC083273. The company has been struck off by the Registrar of Companies and is no longer operational.
Srivenn Formulations had 2 directors:
- Sapna Agarwal - Director
- Manoj Kumar Agarwal - Director
The CIN (Corporate Identification Number) of Srivenn Formulations is U51101TG2012PTC083273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Srivenn Formulations is at 21 – 1 – 732C5 2nd Floor Gopal Market Rikab Gunj, Hyderabad, Telangana, India – 500002.
Srivenn Formulations was incorporated on 25 September 2012. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Srivenn Formulations on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
No. Srivenn Formulations has 1 GST registration on record and it is cancelled or inactive.
Srivenn Formulations operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Srivenn Formulations by revenue are RSND Formulations (OPC) Private Limited, Biored Remedies Private Limited, VL Pharmaceuticals Private Limited, Primd Pharma Private Limited, Boots Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Manoj Kumar Agarwal was appointed as Director on 25 Sep 2012. Sapna Agarwal was appointed as Director on 25 Sep 2012.